RFP - supply of lenalidomide and pomalidomide - DEADLINE EXTENDED TO 11 OCTOBER 2023
Te Pātaka Whaioranga - Pharmac invites proposals for the supply of lenalidomide and/or pomalidomide in the Aotearoa New Zealand subsidised market.
This request for proposals (RFP) incorporates the following schedules:
- Schedule 1 specifies:
- the pharmaceuticals we are seeking proposals for
- the background to the RFP
- our role within the Pae Ora (Healthy Futures) Act 2022
- the types of proposals sought;
- Schedule 2 describes the process that Pharmac expects to follow for the RFP;
- Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceuticals; and
- Schedule 4 contains the RFP form for you to provide your proposal [DOCX, 42 KB].
Full text of RFP - supply of lenalidomide and pomalidomide [PDF, 272 KB]
If you wish to submit a proposal, you must submit it to Pharmac via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz)(external link) no later than 2pm NZT Wednesday 11 October 2023 - RFx ID 27951960.
We encourage suppliers to register with GETS and subscribe to this RFP. If you have any questions about this RFP, please post these on GETS (www.gets.govt.nz(external link)).
We will be accepting questions until 5pm NZT Tuesday 19 September 2023.
We are proposing to hold an online supplier briefing at 11.00 am NZT Thursday 7 September 2023. If you are interested in attending this, please register your interest by emailing procurement@pharmac.govt.nz